For the majority of these cytokines and chemokines, including those that are typically associated with MAS (IL-6, IL-18, IFN-γ, TNF-α, CXCL9) the increase was less pronounced in COVID-19 critical condition than in MAS patients (Fig. 1a). Here, IL18 is linked to COVID-19.